PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Internal Medicine, Bellvitge University Hospital, Bellvitge Biomedical Research Institute-IDIBELL, University of Barcelona, L\'Hospitalet de Llobregat, Barcelona, Spain. Electronic address: mrubio@bellvitgehospital.cat.\', \'Department of Pharmacy, Bellvitge University Hospital, Bellvitge Biomedical Research Institute-IDIBELL, University of Barcelona, L\'Hospitalet de Llobregat, Barcelona, Spain.\', \'Department of Internal Medicine, Bellvitge University Hospital, Bellvitge Biomedical Research Institute-IDIBELL, University of Barcelona, L\'Hospitalet de Llobregat, Barcelona, Spain.\', \'School of Medicine, Universitat Internacional de Catalunya, Sant Cugat del Vallès, Barcelona, Spain.\', \'Department of Pulmonary Medicine, Bellvitge University Hospital, Bellvitge Biomedical Research Institute-IDIBELL, University of Barcelona, L\'Hospitalet de Llobregat, Barcelona, Spain; Research Network in Respiratory Diseases (CIBERES), Madrid, Spain.\', \'Department of Intensive Care, Bellvitge University Hospital, Bellvitge Biomedical Research Institute-IDIBELL, University of Barcelona, L\'Hospitalet de Llobregat, Barcelona, Spain; Innate Immunity and Pathology of Critical Patient-IDIBELL, Barcelona, Spain.\', \'Department of Cardiology, Bellvitge University Hospital, Bellvitge Biomedical Research Institute-IDIBELL, University of Barcelona, L\'Hospitalet de Llobregat, Barcelona, Spain.\', \'Department of Nephrology, Bellvitge University Hospital, Bellvitge Biomedical Research Institute-IDIBELL, University of Barcelona, L\'Hospitalet de Llobregat, Barcelona, Spain.\', \'Department of Gastroenterology, Bellvitge University Hospital, Bellvitge Biomedical Research Institute-IDIBELL, University of Barcelona, L\'Hospitalet de Llobregat, Barcelona, Spain.\', \'Department of Anesthesiology and Reanimation, Bellvitge University Hospital, Bellvitge Biomedical Research Institute-IDIBELL, University of Barcelona, L\'Hospitalet de Llobregat, Barcelona, Spain.\', \'Department of Internal Medicine, Bellvitge University Hospital, Bellvitge Biomedical Research Institute-IDIBELL, University of Barcelona, L\'Hospitalet de Llobregat, Barcelona, Spain; School of Medicine, Universitat Internacional de Catalunya, Sant Cugat del Vallès, Barcelona, Spain. Electronic address: xcorbella@uic.es.\']
?:citedBy
  • -1
?:creator
?:doi
  • S1201-9712(20)32202-510.1016/j.ijid.2020.09.1486
?:doi
?:hasPublicationType
?:journal
  • International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
is ?:pmid of
?:pmid
?:pmid
  • 33035673
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Beneficial effect of corticosteroids in preventing mortality in patients receiving tocilizumab to treat severe COVID-19 illness.
?:type
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33035673>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33035673>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all